Kobuk Therapeutics Overview
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Seed
- Investors
-
1
Kobuk Therapeutics General Information
Description
Developer of a biologics platform designed to address autoimmune diseases by resetting the immune system to a healthy state while preserving protective immunity. The company is currently operating in Stealth Mode.
Contact Information
Website
www.kobuktx.comCorporate Office
- Boston, MA
- United States
Corporate Office
- Boston, MA
- United States
Kobuk Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 01-Oct-2024 | Completed | Stealth |
Kobuk Therapeutics Signals
Kobuk Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cure Ventures | Venture Capital | Minority |
Kobuk Therapeutics FAQs
-
Where is Kobuk Therapeutics headquartered?
Kobuk Therapeutics is headquartered in Boston, MA.
-
What is the size of Kobuk Therapeutics?
Kobuk Therapeutics has 2 total employees.
-
What industry is Kobuk Therapeutics in?
Kobuk Therapeutics’s primary industry is Drug Discovery.
-
Is Kobuk Therapeutics a private or public company?
Kobuk Therapeutics is a Private company.
-
What is Kobuk Therapeutics’s current revenue?
The current revenue for Kobuk Therapeutics is .
-
Who are Kobuk Therapeutics’s investors?
Cure Ventures has invested in Kobuk Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process